{"id":212952,"name":"GLOBAL BLOOD THERAPEUTICS, INC.","slug":"global-blood-therapeutics-inc","state":"CA","country":"United States of America","description":"A biopharmaceutical company with an FDA-approved medicine to treat sickle cell disease","totalSpending":0,"filings":7,"yearlySpending":[{"year":2021,"income":0},{"year":2022,"income":0},{"year":2023,"income":0}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["BLUE STAR STRATEGIES LLC"],"lobbyists":["SALLY PAINTER"],"govEntities":["U.S. Agency for International Development (USAID)","Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Advocating for U.S. government support for treatment of sickle cell disease in developing countries","Seeking support to help GBT develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with sickle cell disease.","Seeking support to help GBT develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with sickle cell disease.","Seeking support to help GBT develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with sickle cell disease.","Seeking support to help GBT develop and deliver life-changing treatments for people living with grievous blood-based disorders, starting with sickle cell disease."]}